Aspire Private Capital’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-700
| Closed | -$1.79K | – | 490 |
|
|
2024
Q3 | $1.79K | Hold |
700
| – | – | ﹤0.01% | 555 |
|
|
2024
Q2 | $2.28K | Hold |
700
| – | – | ﹤0.01% | 544 |
|
|
2024
Q1 | $3.71K | Hold |
700
| – | – | ﹤0.01% | 520 |
|
|
2023
Q4 | $3.03K | Hold |
700
| – | – | ﹤0.01% | 522 |
|
|
2023
Q3 | $1.84K | Hold |
700
| – | – | ﹤0.01% | 569 |
|
|
2023
Q2 | $2.47K | Hold |
700
| – | – | ﹤0.01% | 526 |
|
|
2023
Q1 | $2.16K | Hold |
700
| – | – | ﹤0.01% | 535 |
|
|
2022
Q4 | $2.96K | Hold |
700
| – | – | ﹤0.01% | 490 |
|
|
2022
Q3 | $2K | Hold |
700
| – | – | ﹤0.01% | 521 |
|
|
2022
Q2 | $2K | Hold |
700
| – | – | ﹤0.01% | 503 |
|
|
2022
Q1 | $2K | Hold |
700
| – | – | ﹤0.01% | 508 |
|
|
2021
Q4 | $2K | Buy |
700
+200
| +40% | +$571 | ﹤0.01% | 536 |
|
|
2021
Q3 | $4K | Buy |
+500
| New | +$4K | ﹤0.01% | 418 |
|
|
2021
Q1 | – | Sell |
-500
| Closed | -$5K | – | 592 |
|
|
2020
Q4 | $5K | Hold |
500
| – | – | ﹤0.01% | 301 |
|
|
2020
Q3 | $5K | Buy |
+500
| New | +$5K | ﹤0.01% | 313 |
|
|
2020
Q1 | – | Sell |
-500
| Closed | -$4K | – | 428 |
|
|
2019
Q4 | $4K | Buy |
500
+300
| +150% | +$2.4K | ﹤0.01% | 321 |
|
|
2019
Q3 | $2K | Buy |
+200
| New | +$2K | ﹤0.01% | 367 |
|